Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional Results available

The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

ClinicalTrials.gov ID: NCT00616902

Public ClinicalTrials.gov record NCT00616902. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 3:22 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Clinical Study Protocol M10-221 The PRIMO II Study: Paricalcitol Injection Benefits in Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease (CKD) Stage 5

Study identification

NCT ID
NCT00616902
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
Abbott
Industry
Enrollment
12 participants

Conditions and interventions

Interventions

  • paricalcitol injection 4 mcg/mL Drug
  • Placebo Injection 4 mcg/mL Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Apr 30, 2009
Completion
Apr 30, 2009
Last update posted
Jan 19, 2012

2009

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
27
Facility City State ZIP Site status
Arizona Kidney Disease & Hypertension Center Phoenix Arizona 85027
Southwest Kidney Institute Tempe Arizona 85284
National Institute of Clinical Research Bakersfield California 93309
National Institute of Clinical Research Los Angeles California 90017
University of Southern California Kidney Center Los Angeles California 90033
North American Research Institute - California Kidney Specialist San Dimas California 91773
Kidney Center of Simi Valley Simi Valley California 93065
Western Nephrology and Metabolic bone disease Arvada Colorado 80002
Western Nephrology Westminster Colorado 80031
Washington Nephrology Associates, LLP Washington D.C. District of Columbia 20017
Fresenius Dialysis - Carrollwood Tampa Florida 33624
FMC-NA Central Atlanta Atlanta Georgia 30329
University of Illinois at Chicago - Nephrology Research Chicago Illinois 60612
The University of Chicago - Stony Island Dialysis Unit Chicago Illinois 60617
Evanston Northwestern Healthcare Corp. - Division of Nephrology Evanston Illinois 60201
Research By Design, LLC Evergreen Park Illinois 60805
North Suburban Nephrology Gurnee Illinois 60031
Biolab Research LLC Rockville Maryland 20852
Fresenius Medical Care Kalamazoo Michigan 49007
V.A. Medical Center Research Kansas City Missouri 64128
Washington University School of Medicine - Division of Renal Disease St Louis Missouri 63110
Creighton University Medical Center Omaha Nebraska 68131
Brookdale Physicians Dialysis Associates Brooklyn New York 11212
Nephrology Associates, PLLC Winston-Salem North Carolina 27103-7108
MetroHealth Medical Center Cleveland Ohio 44109
G. Edward Newman, MD, LLC Knoxville Tennessee 37923
V.A. Tennessee Valley Healthcare System Nashville Tennessee 37212
Southwest Houston Research, Ltd Houston Texas 77099
The University of Texas - Health Science Center at San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00616902, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 19, 2012 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00616902 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →